PDS Planning Inc Has $703,000 Stake in Cigna Group $CI

PDS Planning Inc grew its position in shares of Cigna Group (NYSE:CIFree Report) by 5.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,128 shares of the health services provider’s stock after buying an additional 107 shares during the quarter. PDS Planning Inc’s holdings in Cigna Group were worth $703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC acquired a new position in Cigna Group during the first quarter valued at approximately $28,000. 1248 Management LLC acquired a new position in Cigna Group during the first quarter valued at approximately $29,000. Activest Wealth Management grew its holdings in Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares during the last quarter. Retirement Wealth Solutions LLC grew its holdings in Cigna Group by 74.1% during the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 43 shares during the last quarter. Finally, Saudi Central Bank acquired a new position in Cigna Group during the first quarter valued at approximately $36,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

CI opened at $301.00 on Friday. The stock has a market cap of $80.35 billion, a PE ratio of 16.43, a P/E/G ratio of 0.88 and a beta of 0.45. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 1 year low of $256.89 and a 1 year high of $358.88. The stock’s 50 day simple moving average is $294.68 and its 200-day simple moving average is $309.23.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the business posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s payout ratio is currently 32.97%.

Insider Buying and Selling

In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the topic of several analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $365.00 price target on shares of Cigna Group in a report on Tuesday, August 26th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a report on Monday, June 23rd. Robert W. Baird set a $372.00 price target on Cigna Group in a research report on Thursday, August 14th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Finally, Truist Financial set a $375.00 price target on Cigna Group in a research report on Tuesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $372.69.

Read Our Latest Report on CI

Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.